About this trial
The ultimate goal of this research and development is to develop personalized digital healthcare technologies and self-management strategies based on self-assessment results and evidence, for breast cancer survivors who require management and recovery from acute and chronic side effects related to various treatments (surgery, chemotherapy, radiation, hormone therapy, etc.). Additionally, the aim is to verify the clinical applicability and establish a service model to address the diverse unmet healthcare needs of breast cancer survivors.
Eligibility criteria
Qualifiers
Individuals who have undergone surgery for Stage 1-2 breast cancer
Individuals who have had a unilateral mastectomy
Aged 18 years or older and under 65 years
Possessing a smartphone with either an Android or iOS operating system
Disqualifiers
Individuals who have undergone mastectomy only and are not receiving chemotherapy, radiation, or hormone therapy
Individuals with severe comorbidities (such as underlying diseases, neuromuscular disorders, cognitive or mental impairments, visual disabilities, etc.) that make it difficult to use the application or participate in the exercise intervention
Individuals who undergo delayed breast reconstruction surgery during the study period
Individuals who develop severe complications or experience cancer metastasis or recurrence in other organs during the study period, leading to a change in treatment
Trial design
Treatments tested in this trial
- digital health (application and smartwatch)
Treatment groups
Sponsors and collaborators
Samsung Medical Center
Lead sponsor
Pusan National University Yangsan Hospital
Collaborator